Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00485225
Status:
COMPLETED
Last Update Posted:
2012-02-23
First Post:
2007-06-08
Brief Title:
Open Label Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant Chronic Pain
Sponsor:
Durect
Organization:
Durect
Study Overview
Official Title:
An Open-Label Two-Stage Phase II Study to Explore the Titration Schedule for Transitioning Opioid-Experienced Patients With Non-Malignant Moderate to Severe Chronic Pain From Current Opioid Therapy to EN3270
Status:
COMPLETED
Status Verified Date:
2011-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Two stage study looking at different titration schedules in patients with moderate to severe non-malignant chronic pain Up to 80 patients at approximately 15 centers in the US to be enrolled Study participation is approximately 3 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None